Land: Storbritannien
Sprog: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Colestyramine anhydrous
Neon Healthcare Ltd
C10AC01
Colestyramine anhydrous
4gram
Powder for oral suspension
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02120000; GTIN: 5012712002727
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT QUESTRAN LIGHT™*4G/SACHET POWDER FOR ORAL SUSPENSION COLESTYRAMINE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET 1. What QUESTRAN LIGHT is and what it is used for 2. What you need to know before you take QUESTRAN LIGHT 3. How to take QUESTRAN LIGHT 4. Possible side effects 5. How to store QUESTRAN LIGHT 6. Contents of the pack and other information 1. WHAT QUESTRAN LIGHT IS AND WHAT IT IS USED FOR Questran Light is supplied as sachets. Each sachet contains 4g of the active substance colestyramine. Colestyramine belongs to a group of medicines called bile acid binding resins. Questran Light is used to lower your body’s level of cholesterol (a type of fat) which can cause heart disease. This medicine works in the digestive system and absorbs the cholesterol-containing bile acids, which then pass out through the body in the faeces. Questran Light may also be used to help stop some types of diarrhoea or itching. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE QUESTRAN LIGHT DO NOT TAKE QUESTRAN LIGHT: - if you are allergic to colestyramine or any other ingredients of this medicine (listed in section 6), or a similar medicine. - if you have an illness which results in your BILE DUCT BEING COMPLETELY BLOCKED (e.g. gall stones). Check with your doctor if you are unsure. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Questran Light if: - you are in a long-term treatment with high doses of Questran Light as it may reduce the body’s ability to absorb fat-so Læs hele dokumentet
OBJECT 1 QUESTRAN LIGHT Summary of Product Characteristics Updated 28-Nov-2017 | Bristol-Myers Squibb Pharmaceuticals limited 1. Name of the medicinal product Questran Light 4g/sachet Powder for Oral Suspension 2. Qualitative and quantitative composition Each sachet contains 4g anhydrous colestyramine (a basic anion-exchange resin). Excipient with known effect: Questran Light contains 30mg of aspartame per sachet. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Powder for Oral Suspension. 4. Clinical particulars 4.1 Therapeutic indications Questran is used for: 1 . Primary prevention of coronary heart disease in men between 35 and 59 years of age and with primary hypercholesterolaemia who have not responded to diet and other appropriate measures. 2 . Reduction of plasma cholesterol in hypercholesterolaemia, particularly in those patients who have been diagnosed as Fredrickson's Type II (high plasma cholesterol with normal or slightly elevated triglycerides). 3 . Relief of pruritus associated with partial biliary obstruction and primary biliary cirrhosis. 4 . Relief of diarrhoea associated with ileal resection, Crohn's disease, vagotomy and diabetic vagal neuropathy. 5 . Management of radiation-induced diarrhoea. 4.2 Posology and method of administration Posology _Adults_: 1. For primary prevention of coronary heart disease and to reduce cholesterol: After initial introduction over a three to four week period, 3 to 6 Questran sachets per day, administered either as a single daily dose or in divided doses up to four times daily, according to dosage requirements and patient acceptability. Dosage may be modified according to response and can be increased to 9 sachets per day if necessary. Occasional slight gastrointestinal upsets, e.g. constipation, may occur when starting Questran. These usually pass with continued usage of Questran and are minimised by starting therapy gradually. FINAL DOSE REQUIRED WEEK 1 WEEK 2 WEEK 3 WEEK 4 SACHETS PER DAY 3 1 2 3 3 4 1 2 3 4 6 1 2 3 6 2. To relieve prur Læs hele dokumentet